Abstract:Death associated protein-3 (DAP3) was identified as a responsive protein to interferon-gamma-induced cell death which possibly exerts this regulation by interacting with DAP3 binding cell Death enhancer-1 (DELE1), a newly discovered mitochondrial stress protein in response to cell stress signals. Whilst DAP3 has been shown to be aberrantly expressed in several cancer types (i.e. breast cancer), little is known about the relationship between DAP3 and DELE1 in cancers. The present study examined the expression levels of both DAP3 and DELE1 in clinical colorectal cancers (CRCs), as well as their implication on chemoresistance and mechanism behind the action. Firstly, transcript levels of both DAP3 and DELE1 were quantitatively assessed in a clinical cohort of CRC (n=94). Tumour tissues had significantly higher levels of DAP3, but not DELE1 compared with normal tissues. Levels of DAP3 and DELE1 had a significant association with patient's clinical outcomes and local recurrence. DAP3 and DELE1 significantly correlated in normal colorectal tissues but not in tumour tissues. Secondly, the protein levels of DAP3 and DELE1 were evaluated in both normal and tumour colon tissues which showed that both proteins were highly aberrant in CRC tissues. In addition, both DAP3 and DELE1 at transcript and protein levels were identified as prognostic factors for patient's clinical outcomes. Furthermore, in in vitro assays, knocking down DAP3 or DELE1, and in particular both DAP3 and DELE1 together rendered the CRC cells more sensitive to chemotherapy drugs, consistent with clinical findings of the TCGA-COAD datasets. The acquisition of drug sensitivity following the genetic knockdown was independent of the mitochondrial metabolism, as neither DAP3 knockdown nor DELE1 knockdown showed a significant change. In summary, DAP3 and DELE1 are highly aberrant in CRCs, and both molecules are prognostic factors for patient's clinical outcomes and local recurrence, and are indicators for chemoresistance.

DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression

The prognostic significance and regulatory networks of DAP3 in hepatocellular carcinoma microenvironment based on bioinformatics analysis

DIAPH3 Promoted the Growth, Migration and Metastasis of Hepatocellular Carcinoma Cells by Activating Beta-Catenin/tcf Signaling

THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma

Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms

DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells

DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation

CCBE1 promotes mitochondrial fusion by inhibiting the TGF3-DRP1 axis to prevent the progression of hepatocellular carcinoma

Arginine methylation of DDX3 by PRMT1 mediates mitochondrial homeostasis to promote breast cancer metastasis

MiR-324-3p Promotes Tumor Growth Through Targeting DACT1 and Activation of Wnt/β-catenin Pathway in Hepatocellular Carcinoma

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

METTL3-Mediated m6A Modification of FMRP Drives Hepatocellular Carcinoma Progression and Indicates Poor Prognosis

TACC3 Promotes Stemness and is a Potential Therapeutic Target in Hepatocellular Carcinoma

Increased Mitochondrial Fission Promotes Autophagy and Hepatocellular Carcinoma Cell Survival Through the ROS-modulated Coordinated Regulation of the NFKB and TP53 Pathways

Expression of DNMT3B gene in hepatocellular carcinoma and its effect on proliferation, invasion and metastasis of hepatoma cells

Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A

Death Associated Protein‑3 (DAP3) and DAP3 Binding Cell Death Enhancer‑1 (DELE1) in Human Colorectal Cancer, and Their Impacts on Clinical Outcome and Chemoresistance

Mitochondrial Fission-Induced Mtdna Stress Promotes Tumor-Associated Macrophage Infiltration and HCC Progression

DPP3 Promotes Breast Cancer Tumorigenesis by Stabilizing FASN and Promoting Lipid Synthesis.

Expression of MTA3 in Hepatocellular Carcinoma and Its Significance